Integrated Safety Analysis of Vedolizumab for the Treatment of Ulcerative Colitis or Crohn's Disease

被引:0
|
作者
Colombel, Jean-Frederic
Sands, Bruce E.
Feagan, Brian G.
Loftus, Edward V.
Sankoh, Serap
Fox, Irving
Parikh, Asit
Milch, Catherine
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:S113 / S113
页数:1
相关论文
共 50 条
  • [21] The safety and efficacy of vedolizumab for Crohn's disease and ulcerative colitis in the Hunter New England region
    Morrison, S.
    Edwards, G.
    Foster, R.
    Daley, A.
    Lawrence, O.
    Goodsall, T.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 157 - 157
  • [22] Safety of Vedolizumab Alone or With Concomitant Corticosteroids and/or Immunosuppressants in Patients With Ulcerative Colitis or Crohn's Disease
    Loftus, Edward
    Colombel, Jean-Frederic
    Siegel, Corey
    Lewis, James
    Abhyankar, Brihad
    Sankoh, Serap
    Smyth, Michael
    Milch, Catherine
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S478 - S478
  • [23] Population pharmacokinetics of subcutaneous vedolizumab in Crohn's disease and Ulcerative Colitis
    Vreman, N.
    Anjie, S., I
    Gecse, K. B.
    Lowenberg, M.
    D'Haens, G. R. A. M.
    Mathot, R. A. A.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I1256 - I1257
  • [24] Real-world treatment persistence with vedolizumab in Crohn's disease and ulcerative colitis patients
    Raluy, M.
    Fraeman, K.
    Donaldson, R.
    Reynolds, M.
    Smyth, M.
    Demuth, D.
    Khalid, J. M.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S173 - S174
  • [25] Clinical Practice Experience With Subcutaneous Vedolizumab for the Treatment of Patients With Ulcerative Colitis and Crohn's Disease
    Russ, Kirk
    Wojtowicz, Abigail
    Young, Lisa
    Afzali, Anita
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (12S): : S9 - S9
  • [26] Comparing the Efficacy and Safety of Adalimumab and Vedolizumab in Treating Moderate to Severe Crohn's Disease and Ulcerative Colitis
    Merza, Nooraldin
    Nawras, Yusuf
    Saab, Omar
    Dahiya, Dushyant Singh
    Ahmed, Zohaib
    Ranabothu, Meghana
    Boujemaa, Safa
    Hassan, Mona
    Kobeissy, Abdallah
    Lilley, Kirthi
    GASTROENTEROLOGY RESEARCH, 2023, 16 (06) : 289 - 306
  • [27] Good efficacy and safety of vedolizumab in Crohn's disease and ulcerative colitis in a real-world scenario
    Zingone, Fabiana
    Barberio, Brigida
    Compostella, Federico
    Girardin, Giulia
    D'Inca, Renata
    Marinelli, Carla
    Marsilio, Ilaria
    Lorenzon, Greta
    Savarino, Edoardo Vincenzo
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2020, 13
  • [28] Efficacy and safety of vedolizumab in the treatment of ulcerative colitis
    Domenech, Eugeni
    Gisbert, Javier P.
    Gastroenterologia y Hepatologia, 2016, 39 (10): : 677 - 686
  • [29] Population pharmacokinetic modelling of vedolizumab in patients with ulcerative colitis or Crohn's disease
    Rosario, M.
    Dirks, N.
    Gastonguay, M.
    Fox, I.
    Milton, A.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S225 - S226
  • [30] Questions and answers about the management of Crohn's disease and ulcerative colitis with vedolizumab
    Hinojosa del Val, Joaquin
    Barreiro-de Acosta, Manuel
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2019, 42 (10): : 650 - 656